1. Home
  2. NTWK vs CELU Comparison

NTWK vs CELU Comparison

Compare NTWK & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTWK
  • CELU
  • Stock Information
  • Founded
  • NTWK 1997
  • CELU 2016
  • Country
  • NTWK United States
  • CELU United States
  • Employees
  • NTWK N/A
  • CELU N/A
  • Industry
  • NTWK Computer Software: Prepackaged Software
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTWK Technology
  • CELU Health Care
  • Exchange
  • NTWK Nasdaq
  • CELU Nasdaq
  • Market Cap
  • NTWK 50.8M
  • CELU 42.2M
  • IPO Year
  • NTWK 1998
  • CELU N/A
  • Fundamental
  • Price
  • NTWK $4.08
  • CELU $3.24
  • Analyst Decision
  • NTWK
  • CELU
  • Analyst Count
  • NTWK 0
  • CELU 0
  • Target Price
  • NTWK N/A
  • CELU N/A
  • AVG Volume (30 Days)
  • NTWK 63.3K
  • CELU 586.5K
  • Earning Date
  • NTWK 09-29-2025
  • CELU 05-08-2025
  • Dividend Yield
  • NTWK N/A
  • CELU N/A
  • EPS Growth
  • NTWK N/A
  • CELU N/A
  • EPS
  • NTWK 0.02
  • CELU N/A
  • Revenue
  • NTWK $64,127,568.00
  • CELU $54,220,000.00
  • Revenue This Year
  • NTWK N/A
  • CELU $23.29
  • Revenue Next Year
  • NTWK N/A
  • CELU N/A
  • P/E Ratio
  • NTWK $201.96
  • CELU N/A
  • Revenue Growth
  • NTWK 9.18
  • CELU 138.11
  • 52 Week Low
  • NTWK $2.14
  • CELU $1.00
  • 52 Week High
  • NTWK $4.60
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • NTWK 54.88
  • CELU 59.84
  • Support Level
  • NTWK $3.97
  • CELU $3.16
  • Resistance Level
  • NTWK $4.50
  • CELU $3.40
  • Average True Range (ATR)
  • NTWK 0.28
  • CELU 0.34
  • MACD
  • NTWK -0.04
  • CELU -0.03
  • Stochastic Oscillator
  • NTWK 35.80
  • CELU 20.71

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: